Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Reenaers

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Acta Gastro-Enterologica Belgica|December 23, 2021
Essential reading from the editor's deskTim Vanuytsel, Catherine Reenaers
Gut|January 17, 2025
Challenge of treatment de-escalation in inflammatory bowel diseasesCatherine Reenaers, Edouard Louis
World Journal of Gastroenterology|June 3, 2010
Do clinical factors help to predict disease course in inflammatory bowel disease?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Inflammatory Bowel Diseases|September 26, 2008
Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease?Edouard Louis, Catherine Reenaers, Jacques Belaiche
World Journal of Gastroenterology|August 10, 2012
Impact of medical therapies on inflammatory bowel disease complication rateCatherine Reenaers, Jacques Belaiche, Edouard Louis
Therapeutic Advances in Gastroenterology|December 25, 2010
Current directions of biologic therapies in inflammatory bowel diseaseCatherine Reenaers, Edouard Louis, Jacques Belaiche
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we stop?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Inflammatory Bowel Diseases|September 26, 2008
Does the behavior of Crohn's disease change over time?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Therapeutic Advances in Gastroenterology|December 25, 2010
Tailoring the treatment to the individual in Crohn's diseaseEdouard Louis, Jacques Belaiche, Catherine Reenaers
Best Practice & Research. Clinical Gastroenterology|June 7, 2011
Necessity of phenotypic classification of inflammatory bowel diseaseEdouard Louis, Catherine Van Kemseke, Catherine Reenaers
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Acta Gastro-Enterologica Belgica|December 23, 2021
Essential reading from the editor's deskTim Vanuytsel, Catherine Reenaers
Gut|January 17, 2025
Challenge of treatment de-escalation in inflammatory bowel diseasesCatherine Reenaers, Edouard Louis
World Journal of Gastroenterology|June 3, 2010
Do clinical factors help to predict disease course in inflammatory bowel disease?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Inflammatory Bowel Diseases|September 26, 2008
Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease?Edouard Louis, Catherine Reenaers, Jacques Belaiche
World Journal of Gastroenterology|August 10, 2012
Impact of medical therapies on inflammatory bowel disease complication rateCatherine Reenaers, Jacques Belaiche, Edouard Louis
Therapeutic Advances in Gastroenterology|December 25, 2010
Current directions of biologic therapies in inflammatory bowel diseaseCatherine Reenaers, Edouard Louis, Jacques Belaiche
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we stop?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Inflammatory Bowel Diseases|September 26, 2008
Does the behavior of Crohn's disease change over time?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Therapeutic Advances in Gastroenterology|December 25, 2010
Tailoring the treatment to the individual in Crohn's diseaseEdouard Louis, Jacques Belaiche, Catherine Reenaers
Best Practice & Research. Clinical Gastroenterology|June 7, 2011
Necessity of phenotypic classification of inflammatory bowel diseaseEdouard Louis, Catherine Van Kemseke, Catherine Reenaers
Pageof 7